Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India.
Saved in:
| Title: | Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India. |
|---|---|
| Authors: | Gandrala, Divya1 (AUTHOR) drgdivya@basavatarakam.org, Rajappa, Senthil J.1 (AUTHOR), Mallavarapu, Krishnamohan1 (AUTHOR), Santa, A.1 (AUTHOR), Pavan Kumar, B.1 (AUTHOR), Pinninti, Rakesh1 (AUTHOR), Ladda, Pallavi S.1 (AUTHOR), Pathi, Nikhil1 (AUTHOR), Kandem, Sanath1 (AUTHOR), Tewani, Rohan Kamlesh1 (AUTHOR), Thummar, Vipulkumar2 (AUTHOR), Mehta, Priya2 (AUTHOR), Tyagi, Abhishek (AUTHOR) atyagi@wakehealth.edu |
| Source: | International Journal of Breast Cancer. 4/20/2026, Vol. 2026, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20903170 |
|---|---|
| DOI: | 10.1155/ijbc/8863217 |
